Cargando…

Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway

BACKGROUND: Integrin β6 (ITGB6), a key submonomer of integrin αvβ6, plays an important role in epithelial-to-mesenchymal transition (EMT), wound healing, epithelial-derived tumor growth, fibrosis, and epithelial repair. However, the role of ITGB6 in cervical carcinoma (CC) remains elusive. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xiaoxia, Zhu, Yanan, Wang, Xiaoping, Hou, Yanmei, Fang, Yingji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246156/ https://www.ncbi.nlm.nih.gov/pubmed/34268416 http://dx.doi.org/10.21037/atm-21-1669

Ejemplares similares

Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer
por: Zhang, Chunnian, et al.
Publicado: (2023)

Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL-6/JAK/STAT3 pathway in non-small cell lung cancer
por: Zhang, Peng, et al.
Publicado: (2021)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
por: Zheng, Congying, et al.
Publicado: (2023)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway
por: Lyu, Xinran, et al.
Publicado: (2022)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia
por: Sharma, Nitesh D., et al.
Publicado: (2019)

Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway
por: Yao, Jinmei, et al.
Publicado: (2023)

Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer
por: Fan, Xuhui, et al.
Publicado: (2021)

Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway
por: Xin, Yunchao, et al.
Publicado: (2021)

Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
por: Gutiérrez-Hoya, Adriana, et al.
Publicado: (2020)

DDX5 Silencing Suppresses the Migration of Basal cell Carcinoma Cells by Downregulating JAK2/STAT3 Pathway
por: Quan, Zhe, et al.
Publicado: (2019)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
por: Zagozewski, Jamie, et al.
Publicado: (2022)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
por: Li, Hongbo, et al.
Publicado: (2018)

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
por: Goker Bagca, Bakiye, et al.
Publicado: (2020)

Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
por: Huang, Ziwei, et al.
Publicado: (2020)

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
por: Mohrherr, Julian, et al.
Publicado: (2019)

Association analyses of the JAK/STAT signaling pathway with the progression and prognosis of colon cancer
por: Tang, Shengbo, et al.
Publicado: (2019)

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
por: Wu, Cheng-Shyong, et al.
Publicado: (2016)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Role of IL-6/JAK/STAT pathway in inducing vascular insulin resistance
por: Balakrishnan, Aswath, et al.
Publicado: (2014)

Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis()()
por: Jung, In Hye, et al.
Publicado: (2015)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
por: Marino, Ylenia, et al.
Publicado: (2023)

TCN1 Deficiency Inhibits the Malignancy of Colorectal Cancer Cells by Regulating the ITGB4 Pathway
por: Zhu, Xinqiang, et al.
Publicado: (2023)

The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)

Methotrexate Is a JAK/STAT Pathway Inhibitor
por: Thomas, Sally, et al.
Publicado: (2015)

The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
por: Moresi, Viviana, et al.
Publicado: (2019)

Targeting the JAK/STAT pathway in solid tumors
por: Qureshy, Zoya, et al.
Publicado: (2020)

Erratum to inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
Publicado: (2021)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

Curcumol Attenuates Endometriosis by Inhibiting the JAK2/STAT3 Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2022)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
por: Hu, Xue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufbara6ec688ugeavsbjuqk1bv